Armin Arshi | Medicine and Dentistry | Best Researcher Award

Dr. Armin Arshi | Medicine and Dentistry | Best Researcher Award

NYU Langone Health | United States

Author Profile

Scopus

Google Scholar

🌱 Early Academic Pursuits

Dr. Armin Arshi began his academic journey with distinction, graduating Summa Cum Laude with a Bachelor of Science in Bioengineering from UCLA in 2012. He complemented his technical depth with a specialization in Materials Science and Engineering. Driven by a passion for medicine and innovation, he pursued his Doctor of Medicine at the David Geffen School of Medicine at UCLA, earning membership in the prestigious Alpha Omega Alpha (AΩA) Honor Medical Society and receiving multiple academic awards for excellence in research and leadership.

🏥 Professional Endeavors

Following medical school, Dr. Arshi underwent rigorous Orthopaedic Surgery residency training at UCLA, where he served as Administrative Chief Resident. He then pursued a Fellowship in Adult Reconstruction at the Rothman Orthopaedic Institute, a globally respected hub for joint replacement. His clinical career has included prominent roles as Attending Orthopaedic Surgeon at NYU Langone Health and currently at Beach Orthopaedic Specialty Institute and UCI Health in California. As an Assistant Professor at NYU Grossman School of Medicine, he has shaped orthopedic education and research.

🔬 Contributions and Research Focus

Dr. Arshi’s research spans joint arthroplasty, surgical outcomes, infection control, and implant biomechanics. He has authored numerous peer-reviewed publications in elite journals like The Journal of Arthroplasty and Arthroplasty Today, addressing topics from patient follow-up to periprosthetic joint infection and predictive modeling. His innovative studies have earned recognition at prestigious meetings including AAOS, NASS, and Western Orthopaedic Association. He has also contributed to surgical literature through influential book chapters and national guidelines.

🏅 Accolades and Recognition

Dr. Arshi’s excellence has been honored with the Stafford L. Warren Medal (UCLA’s highest medical school award), numerous resident research awards, and national research prizes, including the NIH DEBUT Competition and Howard Hughes Fellowships. His leadership in orthopedics is further affirmed through roles on editorial boards of major journals and review panels, demonstrating both scientific rigor and peer respect.

🌍 Impact and Influence

With a keen focus on evidence-based medicine, Dr. Arshi’s work has impacted clinical decision-making in joint replacement, particularly in VTE prophylaxis, return-to-sport protocols, and implant longevity. His efforts to understand disparities in patient outcomes and enhance surgical education have made significant strides in advancing personalized orthopedic care. He is a thought leader committed to improving both technical standards and patient experiences.

🔮 Legacy and Future Contributions

Poised at the intersection of clinical mastery and academic excellence, Dr. Arshi is a rising force in orthopaedics. His commitment to innovation, mentorship, and multidisciplinary collaboration positions him to be a lasting influence in orthopedic surgery and medical education. As he continues to lead in surgery, research, and institutional quality initiatives, his legacy will shape the next generation of joint reconstruction techniques and orthopedic leaders.

Publications


📄 Patient characteristics associated with loss to follow-up after total joint arthroplasty
Authors: Ruff G, Sarfraz A, Lawrence KW, Arshi A, Rozell JC, Schwarzkopf R
Journal: Journal of Arthroplasty
Year: 2025


📄 Risk of early manipulation in cemented versus cementless total knee arthroplasty: analysis of the American Joint Replacement Registry
Authors: Schaffler B, Zaniletti I, Arshi A, De M, Schwarzkopf R, Rozell JC
Journal: Journal of Arthroplasty
Year: 2025


📄 Why do total joint arthroplasties get canceled on the day of surgery?
Authors: Sandoval CG, Katzman JL, Connolly P, Grossman EL, Arshi A, Schwarzkopf R
Journal: Journal of Arthroplasty
Year: 2025


📄 Total joint arthroplasty patients from distressed communities return to sports and physical activities at lower rates
Authors: Cozzarelli NF, Khan IA, Arshi A, Sherman MB, Fillingham YA
Journal: Journal of Arthroplasty
Year: 2025


📄 Aseptic tibial loosening is associated with thickness of the cement: a radiographic case-control study
Authors: Schaffler B, Robin JX, Katzman J, Arshi A, Rozell JC, Schwarzkopf R
Journal: Journal of Arthroplasty
Year: 2024


Meilang Xue | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Meilang Xue | Medicine and Dentistry | Best Researcher Award

University of Sydney | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits 🎓

Assoc. Prof. Dr. Meilang Xue embarked on her academic journey with a strong passion for biomedical sciences. She earned her PhD from the University of New South Wales in 2002, laying the foundation for a distinguished career in molecular and cellular research. Her early academic years were marked by an inquisitive drive to uncover the intricate mechanisms of inflammatory and autoimmune diseases, setting the stage for groundbreaking discoveries in the field.

Professional Endeavors 🏢

Dr. Xue is currently the Head of the Sutton Arthritis Research Laboratory and the Chief Scientist of the A3BC Biobank at the Institute of Bone & Joint Research, Kolling Institute, University of Sydney. Since joining the Sutton Lab after her PhD, she has been instrumental in advancing the understanding of inflammatory and autoimmune diseases. Her leadership in these roles has facilitated significant research collaborations and the translation of scientific findings into potential therapeutic applications.

Contributions and Research Focus 🔬

Dr. Xue's research primarily explores the molecular and cellular mechanisms underpinning inflammatory and autoimmune conditions. She was the first to elucidate the critical role of the endothelial protein C receptor (EPCR) and its anti-clotting properties within the synovial joint and skin. These discoveries have revolutionized the understanding of rheumatoid arthritis, skin inflammation, and even type 1 diabetes. Her research has been widely recognized in high-impact journals such as Ann Rheum Dis, Arthritis Rheum, Rheumatology, and Journal of Investigative Dermatology. With 92 publications, 25 patents, and over 6,200 citations, her work has significantly contributed to medical science.

Accolades and Recognition 🏆

Dr. Xue's exemplary contributions have earned her numerous prestigious research fellowships and grants exceeding $5 million, funded by the NHMRC, Arthritis Australia, Lincoln Centre, JDRF International, and industry partners. She has been ranked as the 12th world-leading expert in endothelial protein C receptor research, placing her in the top 0.67% of published authors worldwide in this domain. Her h-index of 37 further underscores her influential impact on the field.

Impact and Influence 🌍

Beyond her research, Dr. Xue has played a crucial role in fostering the next generation of scientists. She has mentored and supervised numerous PhD candidates, postdoctoral fellows, honors students, and research assistants. As a committee member of the Kolling Institute’s Musculoskeletal Priority Research Area Leadership Group and the Kolling Research Enabler Group, she continues to shape the direction of musculoskeletal research. Additionally, her work with the A3BC as a Steering Committee member and chief scientist since 2017 has strengthened national and international research collaborations.

Legacy and Future Contributions 📚

Dr. Xue's dedication to scientific excellence ensures a lasting legacy in inflammatory and autoimmune disease research. Her ongoing studies into the protein C system’s role in disease modulation continue to inspire new therapeutic strategies. With her leadership in academia and industry collaborations, she is set to drive further advancements in precision medicine. Her unwavering commitment to research, mentorship, and innovation cements her reputation as a trailblazer in the field of molecular medicine.

Publications


  • 📄 Endothelial Protein C Receptor: A Multifunctional Mediator in the Pathophysiology of Rheumatoid Arthritis
    Author(s): Meilang Xue, Lyn March
    Journal: Cells
    Year: 2025


  • 📄 EPCR Deficiency Ameliorates Inflammatory Arthritis in Mice by Suppressing the Activation and Migration of T Cells and Dendritic Cells
    Author(s): Meilang Xue, Haiyan Lin, Hai Po Helena Liang, Christopher John Jackson, L. M. March
    Journal: Rheumatology (United Kingdom)
    Year: 2024


  • 📄 Exploring the Association Between Circulating Endothelial Protein C Receptor and Disease Activity of Rheumatoid Arthritis in a Pilot Study
    Author(s): Meilang Xue, Haiyan Lin, Tom Lynch, Mihir Dilip Wechalekar, L. M. March
    Journal: Rheumatology Advances in Practice
    Year: 2024


  • 📄 Endothelial Protein C Receptor and 3K3A-Activated Protein C Protect Mice from Allergic Contact Dermatitis in a Contact Hypersensitivity Model
    Author(s): Meilang Xue, Christopher John Jackson, Haiyan Lin, John H. Griffin, L. M. March
    Journal: International Journal of Molecular Sciences
    Year: 2024


  • 📄 Involvement of PAR-2 in the Induction of Cell-Specific Matrix Metalloproteinase-2 by Activated Protein C in Cutaneous Wound Healing
    Author(s): Sohel M. Julovi, Kelly J. McKelvey, Nikita Minhas, Meilang Xue, Christopher John Jackson
    Journal: International Journal of Molecular Sciences
    Year: 2024